AIDS (ISSN 0269-9370) is a prestigious international peer-reviewed journal published monthly by Elsevier in Amsterdam, the Netherlands, that serves as a leading venue for high-impact research in the field of HIV and acquired immunodeficiency syndrome. As a subscription-based, non-open access publication, it is indexed in the Science Citation Index (SCI) and consistently maintains a high impact factor, typically ranking in the top tiers (Zone 1 or Zone 2) of the Chinese Academy of Sciences journal rankings within the medical sciences. The journal’s scope encompasses a comprehensive range of disciplines, including basic virology, clinical therapeutics, epidemiology, prevention strategies, and the social and psychological dimensions of the disease, with a specific focus on publishing rigorous original research and authoritative reviews. Known for its stringent peer-review process and high rejection rates, AIDS commands significant academic respect and attracts a specialized global audience of researchers, clinicians, and public health experts dedicated to advancing the scientific understanding and global management of HIV/AIDS.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com